IRIS
BAIOCCHI, LEONARDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 28.060
EU - Europa 1.876
AS - Asia 1.256
Continente sconosciuto - Info sul continente non disponibili 10
SA - Sud America 10
OC - Oceania 4
AF - Africa 1
Totale 31.217
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 28.048
SG - Singapore 745
UA - Ucraina 355
CN - Cina 349
IE - Irlanda 338
DE - Germania 284
IT - Italia 235
RU - Federazione Russa 184
SE - Svezia 156
GB - Regno Unito 131
KR - Corea 102
FI - Finlandia 81
FR - Francia 44
PL - Polonia 22
BE - Belgio 19
CA - Canada 10
EU - Europa 9
JP - Giappone 9
CZ - Repubblica Ceca 7
IL - Israele 7
IN - India 6
PK - Pakistan 6
NL - Olanda 5
CH - Svizzera 4
HK - Hong Kong 4
TM - Turkmenistan 4
VN - Vietnam 4
AU - Australia 3
BR - Brasile 3
CL - Cile 3
IR - Iran 3
AE - Emirati Arabi Uniti 2
CO - Colombia 2
ES - Italia 2
ID - Indonesia 2
KZ - Kazakistan 2
LT - Lituania 2
LV - Lettonia 2
MY - Malesia 2
RO - Romania 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
DM - Dominica 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
IQ - Iraq 1
KG - Kirghizistan 1
KW - Kuwait 1
MD - Moldavia 1
MV - Maldive 1
MX - Messico 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
TR - Turchia 1
TW - Taiwan 1
Totale 31.217
Salva come PNG Salva come JPEG
Città #
Woodbridge 7.910
Wilmington 7.523
Houston 6.682
Fairfield 1.024
Ann Arbor 667
Singapore 657
Ashburn 472
Chandler 443
Seattle 439
Cambridge 371
Jacksonville 325
Dublin 308
Medford 248
Dearborn 167
Santa Clara 163
Beijing 141
Lawrence 118
Rome 102
San Diego 91
Menlo Park 69
New York 63
Zhengzhou 57
Mülheim 52
Seoul 34
Moscow 28
Milan 24
Palo Alto 24
Falls Church 23
Redwood City 23
Kraków 22
Norwalk 21
Boardman 20
Brussels 19
London 16
Munich 16
San Mateo 16
University Park 16
Creede 15
Nanjing 15
Shanghai 15
Mountain View 14
Hefei 13
Saint Petersburg 11
Washington 11
Los Angeles 10
Verona 10
Guangzhou 9
Helsinki 9
Kilburn 9
Kunming 9
Council Bluffs 8
Engelhard 8
Hangzhou 8
Nuremberg 8
Toronto 8
Colorado Springs 7
Hounslow 7
Miami 7
Tianjin 7
Chiswick 6
Islington 6
Nanchang 6
Jinan 5
Lahore 5
Auburn Hills 4
Brooklyn 4
Fuzhou 4
Shenyang 4
St. George 4
Central 3
Changchun 3
Chengdu 3
Detroit 3
Dong Ket 3
Esslingen am Neckar 3
Florence 3
Frankfurt am Main 3
Hebei 3
Indiana 3
Lappeenranta 3
New Bedfont 3
Olomouc 3
Southwark 3
Xian 3
Almaty 2
Atlanta 2
Bagnoregio 2
Bangkok 2
Brno 2
Cassino 2
Changsha 2
Chongqing 2
Cologne 2
Dubai 2
Enterprise 2
Fiesole 2
Fremont 2
Henrico 2
Indianapolis 2
Kuala Lumpur 2
Totale 28.737
Salva come PNG Salva come JPEG
Nome #
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 512
An unusual endoscopic finding in a patient with melena: Multiple gastric ulcers of regular shape 458
Bile acid depletion and repletion regulate cholangiocyte growth and secretion by a phosphatidylinositol 3-kinase-dependent pathway in rats. 443
Correlation between liver fibrosis and inflammation in patients transplanted for HCV liver disease 441
Cyclosporine A versus tacrolimus monotherapy. Comparison on bile lipids in the first 3 months after liver transplant in humans 440
Primary yolk sac tumor of the liver: incidental finding in a patient transplanted for hepatocellular carcinoma 439
Taurocholate prevents the loss of intrahepatic bile ducts due to vagotomy in bile duct-ligated rats 438
Relationship between GH/IGF-1 Axis, graft recovery, and early survival in patients undergoing liver transplantation 434
Taurohyodeoxycholate- and tauroursodeoxycholate-induced hypercholeresis is augmented in bile duct ligated rats 425
Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence. 420
Physical examination of the liver: Does it make sense in the third millennium? 418
Leptin attenuates ischemia-reperfusion injury in the rat liver. 415
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 414
N-ethyl-tauroursodeoxycholic acid, a novel deconjugation-resistant bile salt analogue: effects of acute feeding in the rat 411
Comment on the PROVE1 and PROVE2 clinical trials: "I was taking a picture of Rapid Virological Response with telaprevir, but the background is unfocused!". 409
Hepatitis C reinfection after liver transplantation in relation to virus genotype 408
Switch to 1.5 grams MMF monotherapy for CNI-related toxicity in liver transplantation is safe and improves renal function, dyslipidemia, and hypertension 406
Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rats through activation of PKC alpha 404
596 403
Lamellar bodies coexist with vesicles and micelles in human gallbladder bile. Ursodeoxycholic acid prevents cholesterol crystal nucleation by increasing biliary lamellae 403
Assembly of biliary lipids in native hepatic bile after orthotopic liver transplantation: a biochemical and ultra-structural study in humans 401
Reduced acute rejection and side effects with neoral in liver transplantation. 397
Dissolution of human cholesterol gallstones in bile salt/lecithin mixtures: effect of bile salt hydrophobicity and various pHs 396
Cholinergic system modulates growth, apoptosis, and secretion of cholangiocytes from bile duct-ligated rats. 395
Complete hbv prophylaxis withdrawal in HBsAg-positive liver transplant recipients after long-term minimal immunosuppression 395
Qualitative patterns of biliary bile acids affect cyclosporine intestinal absorption in liver transplant recipients 394
Ab initio calcineurin inhibitor-based monotherapy immunosuppression after liver transplantation reduces the risk for Pneumocystis jirovecii pneumonia. 394
Estrogens stimulate proliferation of intrahepatic biliary epithelium in rats. 392
Regression of cholangiocyte proliferation after cessation of ANIT feeding is coupled with increased apoptosis. 390
Non-transplant surgical approach to liver-based hereditary haemorrhagic telangiectasia: a first report 387
Liver transplantation for end-stage liver disease related to viral hepatitis 386
Plasma/erythrocyte ribavirin x100 ratio as an indicator of sustained virological response in HCV genotype 1 patients with early virological response 385
Sequential changes in serum and biliary bile acids after liver transplantation 383
A survey on mortality from non-variceal upper gastrointestinal bleeding: Is the emergency referral system adequate? 383
The Tor Vergata weaning of immunosuppression protocols in stable hepatitis C virus liver transplant patients: the 10-year follow-up 383
Short-Term, Low-Dose Use of Tolvaptan as a Bridge Therapy to Expedite Liver Transplant for Severe Hyponatremic, Cirrhotic Patients With High Model for End-Stage Liver Disease Scores 383
Gastrin inhibits cholangiocyte growth in bile duct-ligated rats by interaction with cholecystokinin-B/Gastrin receptors via D-myo-inositol 1,4,5-triphosphate-, Ca(2+)-, and protein kinase C alpha-dependent mechanisms. 382
One-year pilot study on tauroursodeoxycholic acid as an adjuvant treatment after liver transplantation 381
Bile acid feeding induces cholangiocyte proliferation and secretion: evidence for bile acid-regulated ductal secretion. 381
Prevention of hepatitis C recurrence after liver transplantation: An update. 379
Composition and aggregational forms of biliary lipids in human bile after short-term administration of Taurohyodeoxycholic acid 374
Different expression of VEGF and EGFL7 in human hepatocellular carcinoma 374
Evidence of Spontaneous Post-transplant HCV Eradication in Two Failed DAA Treatments Awaiting Liver Transplantation 374
Interferon-alpha treatment of hepatitis D induces tuberculosis exacerbation in an immigrant 373
Protective role of tauroursodeoxycholate during harvesting and cold storage of human liver: a pilot study in transplant recipients. 372
Hepatic steatosis: a specific sign of hepatitis C reinfection after liver transplantation 371
Immunosuppression-Free Liver Transplantation 370
Tauroursodeoxycholate reduces ischemic damage in human allografts: a biochemical and ultrastructural study 367
Liver transplantation for hepatitis C virus end-stage liver cirrhosis as compared with other nonviral indications 365
Plasma clearance of cholyl-lysyl-fluorescein: a pilot study in humans. 362
Cytotoxicity of bile salts against biliary epithelium: a study in isolated bile ductule fragments and isolated perfused rat liver. 362
Patterns of bile salts and biliary lipids early after liver transplantation differentiate patients with unfavorable graft outcome. 361
TUDCA prevents cholestasis and canalicular damage induced by ischemia-reperfusion injury in the rat, modulating PKC alpha-ezrin pathway 361
Gastrin inhibits cholangiocarcinoma growth through increased apoptosis by activation of Ca2+-dependent protein kinase C-alpha. 358
Regulation of cholangiocyte bile secretion. 358
Effect of taurohyodeoxycholic acid, a hydrophilic bile salt, on bile salt and biliary lipid secretion in the rat 358
Cholangiocarcinoma: Challenges and future needs 354
Effect of taurohyodeoxycholic acid on biliary lipid secretion in man: preliminary report 353
Randomized study on in situ liver perfusion techniques: gravity perfusion vs high-pressure perfusion 349
Secretin activation of the apical Na+-dependent bile acid transporter is associated with cholehepatic shunting in rats. 348
A pilot study on the safety and effectiveness of immunosuppression without prednisone after liver transplantation 348
The Tor Vergata weaning off immunosuppression protocol in stable HCV liver transplant patients: the updated follow up at 78 months. 346
Bile acids with differing hydrophilic-hydrophobic properties do not influence cytokine production by human monocytes and murine Kupffer cells 344
Standard bowel cleansing is highly ineffective in cirrhotic patients undergoing screening colonoscopy 335
Oral S-adenosyl-L-methionine (SAMe) administration enhances bile salt conjugation with taurine in patients with liver cirrhosis 333
Immunosuppression without prednisone after liver transplantion is safe and associated with normal early graft function: preliminary results of a randomized study 330
Acute carbon tetrachloride feeding selectively damages large, but not small, cholangiocytes from normal rat liver. 325
Successful management of a same-day emergency delivery and liver transplant in a 27 weeks pregnant woman with fulminant hepatic failure. 316
Ab initio Everolimus-based Versus Standard Calcineurin Inhibitor Immunosuppression Regimen in Liver Transplant Recipients 303
Importance of liver biopsy findings in immunosuppression management: Biopsy monitoring and working criteria for patients with operational tolerance (OT) 295
An unusual duodenal polyp causing anemia in a liver-transplanted patient 282
Clinical Operational Tolerance and Immunosuppression Minimization in Kidney Transplantation: Where Do We Stand? 282
Pitfalls in the reporting of upper endoscopy features in cirrhotic patients 261
Longterm Survival and Cost-Effectiveness of Immunosuppression Withdrawal After Liver Transplantation 241
Dual role of bile acids on the biliary epithelium: Friend or foe? 193
Possible application of melatonin treatment in human diseases of the biliary tract 169
Intention-to-treat survival benefit of liver transplantation in patients with hepatocellular cancer 163
Liver transplantation for hepatocellular carcinoma: Where do we stand? 161
Domino liver transplantation: Where are we now? 157
Tips for TIPS: A combined percutaneous and transjugular approach for intrahepatic portosystemic shunt placement after liver transplant 150
De novo malignancies after liver transplantation: The effect of immunosuppression-personal data and review of literature 142
Liver transplantation in a patient with complete portal vein thrombosis, is there a surgical way out? A case report 138
Soluble CD163 and mannose receptor as markers of liver disease severity and prognosis in patients with primary biliary cholangitis 114
Knockdown of vimentin reduces mesenchymal phenotype of cholangiocytes in the Mdr2−/− mouse model of primary sclerosing cholangitis (PSC) 111
Pro-inflammatory signalling and gut-liver axis in non-alcoholic and alcoholic steatohepatitis: differences and similarities along the path 98
Neuroendocrine Changes in Cholangiocarcinoma Growth 98
Cholangiocarcinoma: Bridging the translational gap from preclinical to clinical development and implications for future therapy 94
Serum Levels of Granulocyte-Macrophage-colony-stimulating Factor and Stem-cell Factor During Liver Regeneration after Partial Hepatectomy in Humans 83
2016 comprehensive update of the Banff working group on liver allograft pathology: Introduction of antibody-mediated rejection 75
Organoids and spheroids as novel models for studying cholestatic liver injury and cholangiocarcinoma 75
Management of cholangiocarcinoma in the third millennium: time to be guided! 73
Hepatitis B virus recurrence after liver transplantation: An old tale or a clear and present danger? 72
Natremia and liver transplantation: The right amount of salt for a good recipe 68
The interplay between mast cells, pineal gland, and circadian rhythm: Links between histamine, melatonin, and inflammatory mediators 66
Kupffer Cells: Inflammation Pathways and Cell-Cell Interactions in Alcohol-Associated Liver Disease 66
Functional Role of the Secretin/Secretin Receptor Signaling During Cholestatic Liver Injury 59
Downregulation of p16 Decreases Biliary Damage and Liver Fibrosis in the Mdr2/ Mouse Model of Primary Sclerosing Cholangitis 57
Current strategies to minimize ischemia-reperfusion injury in liver transplantation: a systematic review 55
The Dynamic Interplay Between Mast Cells, Aging/Cellular Senescence, and Liver Disease 49
Cyclic AMP Signaling in Biliary Proliferation: A Possible Target for Cholangiocarcinoma Treatment? 48
Totale 30.547
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.221
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.221
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.429 0 0 0 0 648 804 733 688 695 696 535 630
2020/20215.377 543 610 552 667 467 835 676 514 108 179 176 50
2021/20221.543 47 275 100 80 33 223 65 69 106 133 75 337
2022/20231.375 154 111 33 135 126 295 150 91 126 22 100 32
2023/2024549 60 16 61 7 113 111 25 19 11 39 4 83
2024/20251.435 88 758 392 175 22 0 0 0 0 0 0 0
Totale 31.596